Orlistat Dosing and Side Effects
Orlistat is dosed at 120 mg three times daily with meals (or 60 mg over-the-counter), but the 2022 AGA guidelines conditionally recommend AGAINST its use due to modest weight loss benefits that are outweighed by significant gastrointestinal side effects and rare but serious hepatotoxicity. 1
Dosing Regimen
Prescription strength: 120 mg capsule taken three times daily with each fat-containing meal (or within 1 hour after eating) 1
Over-the-counter strength: 60 mg capsule three times daily with meals 2
- The dose can be omitted if a meal is very low in fat or skipped entirely 1
- Maximum: 3 capsules daily 2
- Mandatory supplementation: Take a daily multivitamin containing fat-soluble vitamins (A, D, E, K) at bedtime, at least 2 hours apart from orlistat, due to fat malabsorption 1, 2
Drug Interactions Requiring Dose Separation
Certain medications require longer intervals between orlistat doses and closer monitoring 1:
- Cyclosporine (contraindicated in transplant patients) 2
- Levothyroxine
- Warfarin
- Amiodarone
- Antiretrovirals
Side Effects
Gastrointestinal Effects (Very Common)
The mechanism of fat malabsorption predictably causes GI adverse effects in the majority of patients 1:
- Oily spotting/oily stools
- Flatulence with discharge
- Fecal urgency and incontinence
- Loose, frequent stools that may be hard to control 2
Meta-analysis of 12 RCTs showed treatment discontinuations due to GI adverse effects were nearly 3-fold higher with orlistat versus placebo (RR 2.86; 95% CI 1.91-4.30) 1. These effects are transient and diminish with adherence to a low-fat diet (≤30% calories from fat) 1.
Serious Adverse Events (Rare)
Hepatotoxicity: The FDA has documented 13 cases of liver failure (12 cases with 120 mg dose, 1 case with 60 mg dose) 1. The FDA added a black box warning about potential for serious liver injury 1. Stop orlistat immediately if patients develop:
- Itching
- Yellow eyes or skin (jaundice)
- Dark urine
- Loss of appetite 2
Acute kidney injury: Rare cases reported, likely due to increased oxalate absorption leading to enteric hyperoxaluria and calcium oxalate nephropathy 3
Cholelithiasis: Small increased risk of gallstones with weight loss 1
Pancreatitis: Rare but documented 2
Nutritional Deficiencies
Fat-soluble vitamin deficiencies (A, D, E, K) can occur but levels typically remain within normal range with supplementation 1, 3. No significant effects on calcium, phosphorus, magnesium, iron, copper, or zinc balance 3.
Contraindications
Absolute contraindications 2:
- Organ transplant recipients (interferes with immunosuppressants)
- Chronic malabsorption syndromes
- Cholestasis
- Allergy to orlistat
Relative contraindications 1:
- Chronic diarrhea
- Celiac disease
- Inflammatory bowel disease
- History of bariatric surgery
Clinical Efficacy Context
The modest weight loss (mean 2.81 kg or 2.78% total body weight loss versus placebo) 1 must be weighed against the high burden of GI side effects. While orlistat increases the likelihood of achieving ≥5% weight loss (RR 1.71) and ≥10% weight loss (RR 1.94) 1, the AGA guideline panel made a conditional recommendation AGAINST orlistat use, acknowledging that only patients who place exceptionally high value on modest weight loss and low value on GI adverse effects may reasonably choose this treatment 1.
Common Pitfall
Patients often discontinue orlistat due to embarrassing GI side effects (oily spotting, fecal incontinence) that significantly impact quality of life. Counseling patients to maintain a strict low-fat diet (≤30% calories from fat) reduces but does not eliminate these effects 1.